Skip to main content

Nerve Tumors of Childhood and Infancy

  • Chapter
  • First Online:
Diagnostic Assessment and Treatment of Peripheral Nerve Tumors

Abstract

Peripheral nerves are vulnerable to a wide array of inflammatory, infiltrative, hyperplastic, degenerative, and neoplastic processes, the treatment of which depends on accurate clinical and histopathologic assessment. As they are rarely encountered in the pediatric population, peripheral nerve tumors (PNTs) often prove a diagnostic challenge in this cohort. Although many of the tumors seen in the adult population can also present in childhood, their relative contribution to morbidity is divergent between the two cohorts. In fact, lesions that dominate in adults are supplanted by lesser known but highly aggressive pathologies in children. Familiarity with the clinical presentation, diagnostic adjuncts, and therapeutic indications of pediatric PNTs is a requirement for achieving clinical success. It is the goal of this review to summarize the key features of the most commonly encountered pediatric PNTs, highlighting the key considerations in their management and recommended surgical techniques. Lesions will be presented in the context of three broad categories: benign, malignant, and reactive or hyperplastic lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Harms D. Soft tissue sarcomas in the Kiel pediatric tumor registry. Curr Top Pathol. 1995;89:31–45.

    CAS  PubMed  Google Scholar 

  2. Coffin CM, Dehner LP. Peripheral neurogenic tumors of the soft tissues in children and adolescents: a clinicopathologic study of 139 cases. Pediatr Pathol. 1989;9(4):387–407.

    Article  CAS  PubMed  Google Scholar 

  3. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev. 2010;36(4):277–85.

    Article  PubMed  Google Scholar 

  4. Young JL Jr, Ries LG, Silverberg E, Horm JW, Miller RW. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer. 1986;58(2 Suppl):598–602.

    Article  PubMed  Google Scholar 

  5. Keegan TH, Ries LA, Barr RD, et al. Comparison of cancer survival trends in the United States of adolescents and young adults with those in children and older adults. Cancer. 2016;122(7):1009–16.

    Article  PubMed  Google Scholar 

  6. Donner TR, Voorhies RM, Kline DG. Neural sheath tumors of major nerves. J Neurosurg. 1994;81(3):362–73.

    Article  CAS  PubMed  Google Scholar 

  7. Korf BR. Plexiform neurofibromas. Am J Med Genet. 1999;89(1):31–7.

    Article  CAS  PubMed  Google Scholar 

  8. Gabhane SK, Kotwal MN, Bobhate SK. Morphological spectrum of peripheral nerve sheath tumors: a series of 126 cases. Indian J Pathol Microbiol. 2009;52(1):29–33.

    Article  PubMed  Google Scholar 

  9. Ducatman BS, Scheithauer BW, Piepgras DG, Reiman HM, Ilstrup DM. Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer. 1986;57(10):2006–21.

    Article  CAS  PubMed  Google Scholar 

  10. Sorensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986;314(16):1010–5.

    Article  CAS  PubMed  Google Scholar 

  11. Rodriguez FJ, Stratakis CA, Evans DG. Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, carney complex, and related syndromes. Acta Neuropathol. 2012;123(3):349–67.

    Article  PubMed  Google Scholar 

  12. Gorlin RJ, Koutlas IG. Multiple schwannomas, multiple nevi, and multiple vaginal leiomyomas: a new dominant syndrome. Am J Med Genet. 1998;78(1):76–81.

    Article  CAS  PubMed  Google Scholar 

  13. Broehm C, Al-Ibraheemi A, Fritchie KJ. Pediatric non-vestibular schwannoma. Pediatr Dev Pathol. 2017;20(3):232–9.

    Article  PubMed  Google Scholar 

  14. Hornick JL, Fletcher CD. Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol. 2005;29(7):845–58.

    Article  PubMed  Google Scholar 

  15. Ferraresi S, Garozzo D, Bianchini E, Gasparotti R. Perineurioma of the sciatic nerve: a possible cause of idiopathic foot drop in children: report of 4 cases. J Neurosurg Pediatr. 2010;6(5):506–10.

    Article  PubMed  Google Scholar 

  16. Macarenco RS, Ellinger F, Oliveira AM. Perineurioma: a distinctive and underrecognized peripheral nerve sheath neoplasm. Arch Pathol Lab Med. 2007;131(4):625–36.

    Article  PubMed  Google Scholar 

  17. Wilson TJ, Howe BM, Stewart SA, Spinner RJ, Amrami KK. Clinicoradiological features of intraneural perineuriomas obviate the need for tissue diagnosis. J Neurosurg. 2018;129(4):1034–40.

    Article  PubMed  Google Scholar 

  18. Huang Y, Li H, Xiong Z, Chen R. Intraneural malignant perineurioma: a case report and review of literature. Int J Clin Exp Pathol. 2014;7(7):4503–7.

    PubMed  PubMed Central  Google Scholar 

  19. Pina-Oviedo S, Ortiz-Hidalgo C. The normal and neoplastic perineurium: a review. Adv Anat Pathol. 2008;15(3):147–64.

    Article  PubMed  Google Scholar 

  20. Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics. 2002;22(4):911–34.

    Article  PubMed  Google Scholar 

  21. Decarolis B, Simon T, Krug B, et al. Treatment and outcome of ganglioneuroma and ganglioneuroblastoma intermixed. BMC Cancer. 2016;16:542.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Boukovalas S, Rogers H, Boroumand N, Cole EL. Cellular neurothekeoma: a rare tumor with a common clinical presentation. Plast Reconstr Surg Glob Open. 2016;4(8):e1006.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wilson AD, Rigby H, Orlando A. Atypical cellular neurothekeoma—a diagnosis to be aware of. J Plast Reconstr Aesthet Surg. 2008;61(2):186–8.

    Article  PubMed  Google Scholar 

  24. Stark AM, Buhl R, Hugo HH, Mehdorn HM. Malignant peripheral nerve sheath tumours—report of 8 cases and review of the literature. Acta Neurochir. 2001;143(4):357–63; discussion 363–354

    Article  CAS  PubMed  Google Scholar 

  25. Bates JE, Peterson CR, Dhakal S, Giampoli EJ, Constine LS. Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population. Pediatr Blood Cancer. 2014;61(11):1955–60.

    Article  PubMed  Google Scholar 

  26. Huang JH, Zaghloul K, Zager EL. Surgical management of brachial plexus region tumors. Surg Neurol. 2004;61(4):372–8.

    Article  PubMed  Google Scholar 

  27. Woodruff JM. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Am J Med Genet. 1999;89(1):23–30.

    Article  CAS  PubMed  Google Scholar 

  28. Stucky CC, Johnson KN, Gray RJ, et al. Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience. Ann Surg Oncol. 2012;19(3):878–85.

    Article  PubMed  Google Scholar 

  29. Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL. Malignant peripheral nerve sheath tumor: analysis of treatment outcome. Int J Radiat Oncol Biol Phys. 1998;42(2):351–60.

    Article  CAS  PubMed  Google Scholar 

  30. Vauthey JN, Woodruff JM, Brennan MF. Extremity malignant peripheral nerve sheath tumors (neurogenic sarcomas): a 10-year experience. Ann Surg Oncol. 1995;2(2):126–31.

    Article  CAS  PubMed  Google Scholar 

  31. Amirian ES, Goodman JC, New P, Scheurer ME. Pediatric and adult malignant peripheral nerve sheath tumors: an analysis of data from the surveillance, epidemiology, and end results program. J Neurooncol. 2014;116(3):609–16.

    Article  PubMed  Google Scholar 

  32. Casanova M, Ferrari A, Spreafico F, et al. Malignant peripheral nerve sheath tumors in children: a single-institution twenty-year experience. J Pediatr Hematol Oncol. 1999;21(6):509–13.

    Article  CAS  PubMed  Google Scholar 

  33. Carli M, Ferrari A, Mattke A, et al. Pediatric malignant peripheral nerve sheath tumor: the Italian and German Soft Tissue Sarcoma Cooperative Group. J Clin Oncol. 2005;23(33):8422–30.

    Article  PubMed  Google Scholar 

  34. Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol. 2012;123(3):295–319.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Guccion JG, Enzinger FM. Malignant schwannoma associated with von Recklinghausen’s neurofibromatosis. Virchows Arch A Pathol Anat Histol. 1979;383(1):43–57.

    Article  CAS  PubMed  Google Scholar 

  36. Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010;24(1):65–86.

    Article  PubMed  Google Scholar 

  37. Esiashvili N, Anderson C, Katzenstein HM. Neuroblastoma. Curr Probl Cancer. 2009;33(6):333–60.

    Article  PubMed  Google Scholar 

  38. Smith EI, Haase GM, Seeger RC, Brodeur GM. A surgical perspective on the current staging in neuroblastoma—the international neuroblastoma staging system proposal. J Pediatr Surg. 1989;24(4):386–90.

    Article  CAS  PubMed  Google Scholar 

  39. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349(16):1543–54.

    Article  CAS  PubMed  Google Scholar 

  40. Colon NC, Chung DH. Neuroblastoma. Adv Pediatr Infect Dis. 2011;58(1):297–311.

    Google Scholar 

  41. Han W, Wang HM. Refractory diarrhea: a paraneoplastic syndrome of neuroblastoma. World J Gastroenterol. 2015;21(25):7929–32.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Bleeker G, Tytgat GA, Adam JA, et al. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma. Cochrane Database Syst Rev. 2015;9:CD009263.

    Google Scholar 

  44. Whittle SB, Smith V, Doherty E, Zhao S, McCarty S, Zage PE. Overview and recent advances in the treatment of neuroblastoma. Expert Rev Anticancer Ther. 2017;17(4):369–86.

    Article  CAS  PubMed  Google Scholar 

  45. Stasik CJ, Tawfik O. Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous differentiation (malignant triton tumor). Arch Pathol Lab Med. 2006;130(12):1878–81.

    Article  PubMed  Google Scholar 

  46. Li G, Liu C, Liu Y, et al. Analysis of clinical features and prognosis of malignant triton tumor: a report of two cases and literature review. Oncol Lett. 2015;10(6):3551–6.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Cravioto H, Battista A. Clinical and ultrastructural study of painful neuroma. Neurosurgery. 1981;8(2):181–90.

    Article  CAS  PubMed  Google Scholar 

  48. Hanna SA, Catapano J, Borschel GH. Painful pediatric traumatic neuroma: surgical management and clinical outcomes. Childs Nerv Syst. 2016;32(7):1191–4.

    Article  PubMed  Google Scholar 

  49. Vernadakis AJ, Koch H, Mackinnon SE. Management of neuromas. Clin Plast Surg. 2003;30(2):247–68. vii

    Article  PubMed  Google Scholar 

  50. Krishnan KG, Pinzer T, Schackert G. Coverage of painful peripheral nerve neuromas with vascularized soft tissue: method and results. Neurosurgery. 2005;56(2 Suppl):369–78; discussion 369–378

    PubMed  Google Scholar 

  51. Dumanian GA, Potter BK, Mioton LM, et al. Targeted muscle reinnervation treats neuroma and phantom pain in major limb amputees: a randomized clinical trial. Ann Surg. 2019;270(2):238–46.

    Article  PubMed  Google Scholar 

  52. Spinner RJ, Scheithauer BW, Amrami KK. The unifying articular (synovial) origin of intraneural ganglia: evolution-revelation-revolution. Neurosurgery. 2009;65(4 Suppl):A115–24.

    Article  PubMed  Google Scholar 

  53. Rendon D, Pescador D, Cano C, Blanco J. Intraneural ganglion cyst on the external popliteal nerve. BMJ Case Rep. 2014;2014

    Google Scholar 

  54. Kim DH, Murovic JA, Tiel RL, Moes G, Kline DG. A series of 146 peripheral non-neural sheath nerve tumors: 30-year experience at Louisiana State University Health Sciences Center. J Neurosurg. 2005;102(2):256–66.

    Article  PubMed  Google Scholar 

  55. Teles AR, Finger G, Schuster MN, Gobbato PL. Peripheral nerve lipoma: case report of an intraneural lipoma of the median nerve and literature review. Asian J Neurosurg. 2016;11(4):458.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Perez-Lopez C, Gutierrez M, Isla A. Inflammatory pseudotumor of the median nerve. Case report and review of the literature. J Neurosurg. 2001;95(1):124–8.

    Article  CAS  PubMed  Google Scholar 

  57. Mauermann ML, Scheithauer BW, Spinner RJ, et al. Inflammatory pseudotumor of nerve: clinicopathological characteristics and a potential therapy. J Peripher Nerv Syst. 2010;15(3):216–26.

    Article  PubMed  Google Scholar 

  58. Guedes F, Brown RS, Torrao-Junior FJL, Barbosa DAN, Ravanini GAG, Amorim RMP. Pediatric peripheral nerve tumors: clinical and surgical aspects. Childs Nerv Syst. 2019;35(12):2289–97.

    Article  PubMed  Google Scholar 

  59. Valeyrie-Allanore L, Ismaili N, Bastuji-Garin S, et al. Symptoms associated with malignancy of peripheral nerve sheath tumours: a retrospective study of 69 patients with neurofibromatosis 1. Br J Dermatol. 2005;153(1):79–82.

    Article  CAS  PubMed  Google Scholar 

  60. Ogose A, Hotta T, Morita T, et al. Tumors of peripheral nerves: correlation of symptoms, clinical signs, imaging features, and histologic diagnosis. Skeletal Radiol. 1999;28(4):183–8.

    Article  CAS  PubMed  Google Scholar 

  61. Ugarriza LF, Cabezudo JM, Ramirez JM, Lorenzana LM, Porras LF. Bilateral and symmetric C1-C2 dumbbell ganglioneuromas producing severe spinal cord compression. Surg Neurol. 2001;55(4):228–31.

    Article  CAS  PubMed  Google Scholar 

  62. Sughrue ME, Levine J, Barbaro NM. Pain as a symptom of peripheral nerve sheath tumors: clinical significance and future therapeutic directions. J Brachial Plex Peripher Nerve Inj. 2008;3:6.

    PubMed  PubMed Central  Google Scholar 

  63. Kakkar C, Shetty CM, Koteshwara P, Bajpai S. Telltale signs of peripheral neurogenic tumors on magnetic resonance imaging. Indian J Radiol Imaging. 2015;25(4):453–8.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Burt AM, Huang BK. Imaging review of lipomatous musculoskeletal lesions. SICOT J. 2017;3:34.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Panwar J, Mathew A, Thomas BP. Cystic lesions of peripheral nerves: are we missing the diagnosis of the intraneural ganglion cyst? World J Radiol. 2017;9(5):230–44.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Furniss D, Swan MC, Morritt DG, et al. A 10-year review of benign and malignant peripheral nerve sheath tumors in a single center: clinical and radiographic features can help to differentiate benign from malignant lesions. Plast Reconstr Surg. 2008;121(2):529–33.

    Article  CAS  PubMed  Google Scholar 

  67. Chhabra A, Soldatos T, Durand DJ, Carrino JA, McCarthy EF, Belzberg AJ. The role of magnetic resonance imaging in the diagnostic evaluation of malignant peripheral nerve sheath tumors. Indian J Cancer. 2011;48(3):328–34.

    Article  CAS  PubMed  Google Scholar 

  68. Wasa J, Nishida Y, Tsukushi S, et al. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol. 2010;194(6):1568–74.

    Article  PubMed  Google Scholar 

  69. Bhargava R, Parham DM, Lasater OE, Chari RS, Chen G, Fletcher BD. MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol. 1997;27(2):124–9.

    Article  CAS  PubMed  Google Scholar 

  70. Levine E, Huntrakoon M, Wetzel LH. Malignant nerve-sheath neoplasms in neurofibromatosis: distinction from benign tumors by using imaging techniques. AJR Am J Roentgenol. 1987;149(5):1059–64.

    Article  CAS  PubMed  Google Scholar 

  71. Matsumine A, Kusuzaki K, Nakamura T, et al. Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI. J Cancer Res Clin Oncol. 2009;135(7):891–900.

    Article  PubMed  Google Scholar 

  72. Broski SM, Johnson GB, Howe BM, et al. Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors. Skeletal Radiol. 2016;45(8):1097–105.

    Article  PubMed  Google Scholar 

  73. Karsy M, Guan J, Ravindra VM, Stilwill S, Mahan MA. Diagnostic quality of magnetic resonance imaging interpretation for peripheral nerve sheath tumors: can malignancy be determined? J Neurol Surg A Cent Eur Neurosurg. 2016;77(6):495–504.

    Article  PubMed  Google Scholar 

  74. Demehri S, Belzberg A, Blakeley J, Fayad LM. Conventional and functional MR imaging of peripheral nerve sheath tumors: initial experience. AJNR Am J Neuroradiol. 2014;35(8):1615–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Ahlawat S, Blakeley JO, Langmead S, Belzberg AJ, Fayad LM. Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. Skeletal Radiol. 2020;49(2):199–219.

    Article  PubMed  Google Scholar 

  76. Ahlawat S, Blakeley JO, Rodriguez FJ, Fayad LM. Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Neurology. 2019;93(11):e1076–84.

    Article  CAS  PubMed  Google Scholar 

  77. Chhabra A, Thakkar RS, Andreisek G, et al. Anatomic MR imaging and functional diffusion tensor imaging of peripheral nerve tumors and tumorlike conditions. AJNR Am J Neuroradiol. 2013;34(4):802–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Schmidt M, Kasprian G, Amann G, Duscher D, Aszmann OC. Diffusion tensor tractography for the surgical management of peripheral nerve sheath tumors. Neurosurg Focus. 2015;39(3):E17.

    Article  PubMed  Google Scholar 

  79. Benz MR, Czernin J, Dry SM, et al. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer. 2010;116(2):451–8.

    Article  CAS  PubMed  Google Scholar 

  80. Ferner RE, Golding JF, Smith M, et al. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ann Oncol. 2008;19(2):390–4.

    Article  CAS  PubMed  Google Scholar 

  81. Solomon SB, Semih Dogan A, Nicol TL, Campbell JN, Pomper MG. Positron emission tomography in the detection and management of sarcomatous transformation in neurofibromatosis. Clin Nucl Med. 2001;26(6):525–8.

    Article  CAS  PubMed  Google Scholar 

  82. Cardona S, Schwarzbach M, Hinz U, et al. Evaluation of F18-deoxyglucose positron emission tomography (FDG-PET) to assess the nature of neurogenic tumours. Eur J Surg Oncol. 2003;29(6):536–41.

    Article  CAS  PubMed  Google Scholar 

  83. Khiewvan B, Macapinlac HA, Lev D, et al. The value of (1)(8)F-FDG PET/CT in the management of malignant peripheral nerve sheath tumors. Eur J Nucl Med Mol Imaging. 2014;41(9):1756–66.

    Article  CAS  PubMed  Google Scholar 

  84. Telleman JA, Stellingwerff MD, Brekelmans GJ, Visser LH. Nerve ultrasound in neurofibromatosis type 1: a follow-up study. Clin Neurophysiol. 2018;129(2):354–9.

    Article  PubMed  Google Scholar 

  85. Nguyen R, Jett K, Harris GJ, Cai W, Friedman JM, Mautner VF. Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. J Neurooncol. 2014;116(2):307–13.

    Article  CAS  PubMed  Google Scholar 

  86. Levi AD, Ross AL, Cuartas E, Qadir R, Temple HT. The surgical management of symptomatic peripheral nerve sheath tumors. Neurosurgery. 2010;66(4):833–40.

    Article  PubMed  Google Scholar 

  87. Pianta M, Chock E, Schlicht S, McCombe D. Accuracy and complications of CT-guided core needle biopsy of peripheral nerve sheath tumours. Skeletal Radiol. 2015;44(9):1341–9.

    Article  PubMed  Google Scholar 

  88. Mazal AT, Ashikyan O, Cheng J, Le LQ, Chhabra A. Diffusion-weighted imaging and diffusion tensor imaging as adjuncts to conventional MRI for the diagnosis and management of peripheral nerve sheath tumors: current perspectives and future directions. Eur Radiol. 2019;29(8):4123–32.

    Article  PubMed  Google Scholar 

  89. Huang JH, Simon SL, Nagpal S, Nelson PT, Zager EL. Management of patients with schwannomatosis: report of six cases and review of the literature. Surg Neurol. 2004;62(4):353–61; discussion 361

    Article  PubMed  Google Scholar 

  90. Huang JH, Johnson VE, Zager EL. Tumors of the peripheral nerves and plexuses. Curr Treat Options Neurol. 2006;8(4):299–308.

    Article  PubMed  Google Scholar 

  91. Huang JH, Zhang J, Zager EL. Diagnosis and treatment options for nerve sheath tumors. Expert Rev Neurother. 2005;5(4):515–23.

    Article  PubMed  Google Scholar 

  92. Ranalli NJ, Huang JH, Lee EB, Zhang PJ, Siegelman ES, Zager EL. Hemangiomas of the brachial plexus: a case series. Neurosurgery. 2009;65(4 Suppl):A181–8.

    Article  PubMed  Google Scholar 

  93. Stone JJ, Puffer RC, Spinner RJ. Interfascicular resection of benign peripheral nerve sheath tumors. JBJS Essent Surg Tech. 2019;9(2):e18.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Stone JJ, Spinner RJ. Go for the gold: a “plane” and simple technique for resecting benign peripheral nerve sheath tumors. Oper Neurosurg (Hagerstown). 2020;18(1):60–8.

    Article  Google Scholar 

  95. Russell SM. Preserve the nerve: microsurgical resection of peripheral nerve sheath tumors. Neurosurgery. 2007;61(3 Suppl):113–7; discussion 117–118

    PubMed  Google Scholar 

  96. Baehring JM, Betensky RA, Batchelor TT. Malignant peripheral nerve sheath tumor: the clinical spectrum and outcome of treatment. Neurology. 2003;61(5):696–8.

    Article  PubMed  Google Scholar 

  97. Anghileri M, Miceli R, Fiore M, et al. Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution. Cancer. 2006;107(5):1065–74.

    Article  PubMed  Google Scholar 

  98. Leaphart C, Rodeberg D. Pediatric surgical oncology: management of rhabdomyosarcoma. Surg Oncol. 2007;16(3):173–85.

    Article  PubMed  Google Scholar 

  99. Giuliani S, Marachelian A, Franklin A, Shimada H, Grikscheit T. Forearm skeletal muscle neuroblastoma in a child: a rare primary location. J Pediatr Hematol Oncol. 2013;35(1):61–3.

    Article  PubMed  Google Scholar 

  100. Landy H, Feun L, Markoe A, et al. Extended remission of a recurrent median nerve malignant peripheral nerve sheath tumor after multimodal treatment. Case report. J Neurosurg. 2005;103(4):760–3.

    Article  PubMed  Google Scholar 

  101. Guha D, Davidson B, Nadi M, et al. Management of peripheral nerve sheath tumors: 17 years of experience at Toronto Western Hospital. J Neurosurg. 2018;128(4):1226–34.

    Article  PubMed  Google Scholar 

  102. Kim DH, Murovic JA, Tiel RL, Moes G, Kline DG. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center. J Neurosurg. 2005;102(2):246–55.

    Article  PubMed  Google Scholar 

  103. Vetrano IG, Lucarella F, Dalolio M, et al. The importance of predicting factors in the surgical outcome of peripheral nerve sheath tumors. J Neurol Surg A Cent Eur Neurosurg. 2014;75(2):104–9.

    PubMed  Google Scholar 

  104. Artico M, Cervoni L, Wierzbicki V, D’Andrea V, Nucci F. Benign neural sheath tumours of major nerves: characteristics in 119 surgical cases. Acta Neurochir. 1997;139(12):1108–16.

    Article  CAS  PubMed  Google Scholar 

  105. Requena L, Sangueza OP. Benign neoplasms with neural differentiation: a review. Am J Dermatopathol. 1995;17(1):75–96.

    Article  CAS  PubMed  Google Scholar 

  106. deCou JM, Rao BN, Parham DM, et al. Malignant peripheral nerve sheath tumors: the St. Jude Children’s Research Hospital experience. Ann Surg Oncol. 1995;2(6):524–9.

    Article  CAS  PubMed  Google Scholar 

  107. An HY, Hong KT, Kang HJ, et al. Malignant peripheral nerve sheath tumor in children: a single-institute retrospective analysis. Pediatr Hematol Oncol. 2017;34(8):468–77.

    Article  CAS  PubMed  Google Scholar 

  108. Farid M, Demicco EG, Garcia R, et al. Malignant peripheral nerve sheath tumors. Oncologist. 2014;19(2):193–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Valentin T, Le Cesne A, Ray-Coquard I, et al. Management and prognosis of malignant peripheral nerve sheath tumors: the experience of the French Sarcoma Group (GSF-GETO). Eur J Cancer. 2016;56:77–84.

    Article  CAS  PubMed  Google Scholar 

  110. Zou C, Smith KD, Liu J, et al. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome. Ann Surg. 2009;249(6):1014–22.

    Article  PubMed  Google Scholar 

  111. Kolberg M, Holand M, Agesen TH, et al. Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1. Neuro Oncol. 2013;15(2):135–47.

    Article  CAS  PubMed  Google Scholar 

  112. Kahn J, Gillespie A, Tsokos M, et al. Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors. Front Oncol. 2014;4:324.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res. 2002;62(5):1573–7.

    CAS  PubMed  Google Scholar 

  114. Sordillo PP, Helson L, Hajdu SI, et al. Malignant schwannoma—clinical characteristics, survival, and response to therapy. Cancer. 1981;47(10):2503–9.

    Article  CAS  PubMed  Google Scholar 

  115. Grobmyer SR, Reith JD, Shahlaee A, Bush CH, Hochwald SN. Malignant peripheral nerve sheath tumor: molecular pathogenesis and current management considerations. J Surg Oncol. 2008;97(4):340–9.

    Article  CAS  PubMed  Google Scholar 

  116. Alvarado CS, London WB, Look AT, et al. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study. J Pediatr Hematol Oncol. 2000;22(3):197–205.

    Article  CAS  PubMed  Google Scholar 

  117. De Bernardi B, Mosseri V, Rubie H, et al. Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group. Br J Cancer. 2008;99(7):1027–33.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Strother DR, London WB, Schmidt ML, et al. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma: results of Children’s Oncology Group study P9641. J Clin Oncol. 2012;30(15):1842–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  119. Baker DL, Schmidt ML, Cohn SL, et al. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma. N Engl J Med. 2010;363(14):1313–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Yanik GA, Parisi MT, Shulkin BL, et al. Semiquantitative mIBG scoring as a prognostic indicator in patients with stage 4 neuroblastoma: a report from the Children’s Oncology Group. J Nucl Med. 2013;54(4):541–8.

    Article  CAS  PubMed  Google Scholar 

  121. Simon T, Haberle B, Hero B, von Schweinitz D, Berthold F. Role of surgery in the treatment of patients with stage 4 neuroblastoma age 18 months or older at diagnosis. J Clin Oncol. 2013;31(6):752–8.

    Article  PubMed  Google Scholar 

  122. Du L, Liu L, Zhang C, et al. Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy. J Pediatr Surg. 2014;49(4):528–33.

    Article  PubMed  Google Scholar 

  123. Adkins ES, Sawin R, Gerbing RB, London WB, Matthay KK, Haase GM. Efficacy of complete resection for high-risk neuroblastoma: a Children’s Cancer Group study. J Pediatr Surg. 2004;39(6):931–6.

    Article  PubMed  Google Scholar 

  124. Modak S, Cheung NK. Neuroblastoma: therapeutic strategies for a clinical enigma. Cancer Treat Rev. 2010;36(4):307–17.

    Article  CAS  PubMed  Google Scholar 

  125. Meza JL, Anderson J, Pappo AS, Meyer WH, Children’s Oncology Group. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children’s Oncology Group. J Clin Oncol. 2006;24(24):3844–51.

    Article  PubMed  Google Scholar 

  126. Stevens MC, Rey A, Bouvet N, et al. Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology—SIOP malignant mesenchymal tumor 89. J Clin Oncol. 2005;23(12):2618–28.

    Article  PubMed  Google Scholar 

  127. Date R, Muramatsu K, Ihara K, Taguchi T. Advantages of intra-capsular micro-enucleation of schwannoma arising from extremities. Acta Neurochir. 2012;154(1):173–8; discussion 178

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric L. Zager .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Kvint, S., Ali, Z.S., Jacques, L.G., Heuer, G., Zager, E.L. (2021). Nerve Tumors of Childhood and Infancy. In: Guedes, F., Zager, E.L., Garozzo, D., Rasulic, L., Socolovsky, M. (eds) Diagnostic Assessment and Treatment of Peripheral Nerve Tumors. Springer, Cham. https://doi.org/10.1007/978-3-030-77633-6_23

Download citation

Publish with us

Policies and ethics